HDAC inhibitors, SAHA and LBH589, were found to regulate PGD2 production and CRTH2 expression, and high-concentration PGD2 and CRTH2 inhibitor AZD1981 enhanced their cytotoxicity in DLBCL. This evidence concerns the gene HDAC9 and diffuse large B-cell lymphoma.